Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cogent Biosciences Inc

COGT
Current price
6.71 USD +0.13 USD (+1.98%)
Last closed 6.61 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 636 785 216 USD
Yield for 12 month -39.66 %
1Y
3Y
5Y
10Y
15Y
COGT
21.11.2021 - 28.11.2021

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Address: 275 Wyman Street, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.7 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 588 000 USD

Last Year

-5 878 000 USD

Current Quarter

-794 000 USD

Last Quarter

-855 000 USD

Key Figures COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -205 860 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -42.36 %
PEG Ratio
Return On Equity TTM -74.93 %
Wall Street Target Price 16.7 USD
Revenue TTM
Book Value 2.3 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM -121 627 000 USD
Earnings Share -2.42 USD
Diluted Eps TTM -2.42 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics COGT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:4
Payout Ratio
Last Split Date 09.11.2020
Dividend Date 09.11.2020

Stock Valuation COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 925.407
Price Sales TTM 1320.6301
Enterprise Value EBITDA -2.1297
Price Book MRQ 3.1474

Financials COGT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators COGT

For 52 weeks

3.67 USD 13.5 USD
50 Day MA 6.8 USD
Shares Short Prior Month 9 633 534
200 Day MA 8.55 USD
Short Ratio 5.76
Shares Short 10 841 477
Short Percent 11.68 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics